BPC 5mg + TB 5mg

Potential Synergistic Effects

• BPC-157 (Body Protection Compound-157): Typically targets localized healing. It is associated with angiogenesis (new blood vessel formation) and collagen synthesis, specifically for tendons, ligaments, and the gut.
• TB-500 (Thymosin Beta-4 Fragment): Believed to act systemically to support broader cell migration and muscle remodeling. It helps immune cells and fibroblasts travel to injury sites more efficiently. 

Common Handling and Storage

• Formulation: These are often sold as a lyophilized (freeze-dried) powder in a single vial containing 5mg of each peptide.
• Reconstitution: The powder is mixed with a sterile solvent, such as bacteriostatic water. Solutions should be swirled gently, never shaken, as peptides are delicate.
• Storage: Reconstituted vials must be refrigerated between uses to maintain stability. 

2026 Safety and Regulatory Status

• FDA Status: As of 2026, neither BPC-157 nor TB-500 is FDA-approved for human use.
• Compounding Restrictions: The FDA has classified BPC-157 as a “Category 2 Bulk Drug Substance” due to safety concerns, effectively barring licensed compounding pharmacies from preparing it for human consumption.
• Athletic Bans: BPC-157 is explicitly listed as a prohibited substance by the World Anti-Doping Agency (WADA) under the S0 category.
• Clinical Data: While animal studies are extensive, human clinical data remains limited. Potential risks include immune reactions and issues with impurities from unregulated production.